Stock listing
Lipocine Inc.
Selected listing: LPCN · NASDAQ · USD · US
Lipocine Inc. (NASDAQ:LPCN), Health Technology. Latest release Sep 14, 2026: Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum…
- Ticker
- NASDAQ:LPCN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Lipocine Inc.
Lipocine Inc. is a public company traded under the ticker LPCN in the American market. The company is committed to advancing its product pipeline to address unmet medical needs.
Latest news from Lipocine Inc.
Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression
September 14, 2026
Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
Lipocine : Appoints Michael J. Grissinger to Board of Directors
August 3, 2026
Lipocine Appoints Michael J. Grissinger to Board of Directors
August 3, 2026
Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
June 3, 2026